Share Email Print
cover

Proceedings Paper

Clinical photodynamic therapy of malignant neoplasms
Author(s): Eugeny Ph. Stranadko; Oleg K. Skobelkin; Gregory Litwin; Tamara A. Astrakhankina
Format Member Price Non-Member Price
PDF $14.40 $18.00

Paper Abstract

The analysis of the results of treatment of 379 malignant neoplasms with PDT in 89 patients has been made. Photogem (hematoporphyrin derivative) and Photosense (aluminum sulfonated derivative) -- both produced in Russia -- were used as photosensitizers. An argon-pumped dye- laser called `Innova 200' (Coherent USA), a Russian dye laser with copper vapor pumping (Yakhroma 2), a gold vapor laser (630 nm and 627.8 nm, accordingly) for Photogem, and a solid aluminate ittrium laser (672 nm) for Photosense were used. Up to now we have had follow-up control of 75 patients for the period of 2 months to 2.5 years. Positive effect of PDT was seen in 90.7% (68 out of 75); including complete regression -39 (52%), partial (50 - 100%), -in 29 (38.7%).

Paper Details

Date Published: 12 January 1995
PDF: 7 pages
Proc. SPIE 2325, Photodynamic Therapy of Cancer II, (12 January 1995); doi: 10.1117/12.199150
Show Author Affiliations
Eugeny Ph. Stranadko, State Research Ctr. for Laser Medicine (Russia)
Oleg K. Skobelkin, State Research Ctr. for Laser Medicine (Russia)
Gregory Litwin, State Research Ctr. for Laser Medicine (Russia)
Tamara A. Astrakhankina, State Research Ctr. for Laser Medicine (Russia)


Published in SPIE Proceedings Vol. 2325:
Photodynamic Therapy of Cancer II

© SPIE. Terms of Use
Back to Top